Kronox Lab Sciences Ltd

Ticker: KRONOX
Decent 66/100

☆ Add to Watchlist

Investing Reference

Price
148.32
Market Cap
550.33
Debt/Equity
0.0000
ROE %
32.583
PB
6.1080
Promoter %
74.208
Pledge %
0.000
1Y Rev Growth %
12.336
5Y Rev Growth %
14.776
NP Margin %
24.805
NP Margin 5Y Avg %
19.341

Trading Reference

1M Return %
-15.345
6M Return %
-0.829
1Y Return %
-13.370
% Away 52W High
54.315
% Away 52W Low
12.321
Daily Volume
165052
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 25/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Kronox Lab Sciences Ltd is currently trading near a strong support level, with the 50-day EMA indicating bullish momentum. If the stock breaks above the resistance level, it could see a significant upside. However, if it falls below the support, there could be a notable downside risk.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Kronox Lab Sciences Ltd is a pioneering company in the Indian biotechnology sector, dedicated to advancing healthcare through innovative laboratory solutions. Catering to hospitals, research institutions, and pharmaceutical companies, Kronox focuses on delivering high-quality diagnostic services and products. Their commitment to excellence enhances patient care and supports medical research, making them a vital player in the healthcare landscape. With a strong emphasis on technology and reliability, Kronox is poised for significant growth in the rapidly evolving life sciences industry.

  • Pioneering biotechnology solutions in India
  • Focus on high-quality diagnostic services
  • Supports hospitals and research institutions
  • Commitment to innovation and technology
  • Enhances patient care and medical research
  • Strong growth potential in life sciences

Investment Thesis

Kronox Lab Sciences Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. These factors position it well for future expansion and profitability, making it a compelling investment opportunity for retail investors.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Rapid growth in digital services presents significant revenue potential.
  • Valuation metrics remain attractive compared to industry peers, indicating upside.
  • Strategic focus on innovation and technology positions the company for long-term success.
  • Solid fundamentals and market positioning make it a reliable investment choice.

Opportunity vs Risk

Opportunities
  • Growing demand for biotech solutions
  • Expansion into international markets
  • Strong R&D pipeline
  • Strategic partnerships with key players
Risks ⚠️
  • Regulatory hurdles in biotech
  • High competition in industry
  • Market volatility affecting stock prices
  • Dependence on successful product launches

Peer Perspective

Kronox Lab Sciences Ltd is currently trading at a discount to peers like Biocon and Dr. Reddy's Laboratories, with potential for rerating contingent on achieving consistent margin stability and accelerating revenue growth.
📊 Stock Investment Checklist (100 Points)
Kronox Lab Sciences Ltd • Updated: 2025-09-17 03:14:06
  • 10
    Business
    High
    The sector is growing with increasing demand for lab services, but the company lacks a strong competitive moat.
  • 10
    Growth
    High
    Revenue growth has been consistent, but profit margins are fluctuating.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, and cash flow is inconsistent.
  • 8
    Valuation
    High
    P/E and P/B ratios are higher than peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios are concerning.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are some concerns regarding disclosures.
  • 5
    Drivers
    Good
    Growth drivers exist, but execution risks are significant.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100 • Decent
Kronox Lab Sciences Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 65/100
  • Growth Potential: 70/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.